Furthermore, the outer cell fate of CT45A1 (+) cells in a CIC structure was observed in MSI‐H CRC tumor sections, and MSI‐H CRC patients with upregulated CT45A1 expression exhibited increased MLC2 phosphorylation and poor clinical outcomes. The gene discussed is MYL9; the disease is neoplasm.